Literature DB >> 11214939

Homocysteine and human reproduction.

T K Eskes.   

Abstract

Homocysteine is an amino acid that is capable of disturbing the proper growth of cells. Hyperhomocysteinemia can lead to a non-closure of the neural tube. The underlying basis is a derangement of homocysteine metabolism due to a missense mutation of the MTHFR enzyme that has to catalyze the folate metabolic cycle furnishing sufficient methyl groups for DNA and tRNA synthesis. Folate can overcome the dysfunction of the mutation and the decreased activity of the thermolabile MTHFR. Homocysteine is also recognized as an independent risk factor for obstetrical vascular disease that can manifest itself in maternal veins (thrombosis), arteries (preeclampsia) or spiral arteries supplying the placenta (placental abruption). Low vitamin status (folic acid, vitamin B6 and B12), hyperhomocysteinemia, the MTHFR gene mutation C677T, and thrombotic factors like Protein C, Protein S. antithrombin III, factor V Leiden and Activated Protein C, are alone or in combination high risk factors for obstetrical vascular disease. Their values can be modulated by B-vitamin status and could be able to prevent disease from occurring or recurring. Placebo-randomized trials have been done in neural tube defects but are urgently needed in the vascular area. The common denominator of the effect of homocysteine on the embryo and the blood vessels (endothelium) could be sited in the process of proliferation of cells that need proper methyl groups for proper function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214939

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  7 in total

Review 1.  Effects and safety of periconceptional folate supplementation for preventing birth defects.

Authors:  Luz Maria De-Regil; Ana C Fernández-Gaxiola; Therese Dowswell; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Methionine, homocysteine, one carbon metabolism and fetal growth.

Authors:  Satish C Kalhan; Susan E Marczewski
Journal:  Rev Endocr Metab Disord       Date:  2012-06       Impact factor: 6.514

Review 3.  One carbon metabolism in pregnancy: Impact on maternal, fetal and neonatal health.

Authors:  Satish C Kalhan
Journal:  Mol Cell Endocrinol       Date:  2016-06-04       Impact factor: 4.102

4.  Maternal folate, one-carbon metabolism and pregnancy outcomes.

Authors:  Tanja Jankovic-Karasoulos; Denise L Furness; Shalem Y Leemaqz; Gustaaf A Dekker; Luke E Grzeskowiak; Jessica A Grieger; Prabha H Andraweera; Dylan McCullough; Dale McAninch; Lesley M McCowan; Tina Bianco-Miotto; Claire T Roberts
Journal:  Matern Child Nutr       Date:  2020-07-28       Impact factor: 3.092

5.  Melatonin Alleviates the Toxicity of High Nicotinamide Concentrations in Oocytes: Potential Interaction with Nicotinamide Methylation Signaling.

Authors:  Marwa El-Sheikh; Ahmed Atef Mesalam; Seok-Hwan Song; Jonghyeok Ko; Il-Keun Kong
Journal:  Oxid Med Cell Longev       Date:  2021-04-08       Impact factor: 6.543

Review 6.  Effects and safety of periconceptional oral folate supplementation for preventing birth defects.

Authors:  Luz Maria De-Regil; Juan Pablo Peña-Rosas; Ana C Fernández-Gaxiola; Pura Rayco-Solon
Journal:  Cochrane Database Syst Rev       Date:  2015-12-14

7.  The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.

Authors:  Natalie K Björklund; Jane A Evans; Cheryl R Greenberg; Lorne E Seargeant; Carol E Schneider; Bernard N Chodirker
Journal:  Reprod Biol Endocrinol       Date:  2004-09-07       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.